A Comparative Study of Ayurvedic Formulations in the Management Of Kamala
Phase 1
Completed
- Conditions
- Health Condition 1: K769- Liver disease, unspecified
- Registration Number
- CTRI/2020/06/026061
- Lead Sponsor
- College Principal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 25
Inclusion Criteria
Patient willing to undergo trial and ready to give written consent
Patient presenting with classical feature of Kamala and impaired liver functions
Total serum bilirubin-2 to 10 mg/dl
SGOT-50 to 1000 IU/L
SGPT- 50 to 1000 IU/
Exclusion Criteria
Patient not willing for trial
Patient below the age of 20 years and above 60 years
Patient having malignancy and acute hepatocellular failure.
Patient requiring surgical intervention(obstructive jaundice)
Total serum bilirubin- <2mg/dl or >10mg/dl
SGOT >1000 IU/L
SGPT >1000 IU/L
S.ALP >3 Times the normal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fulfillment of subjective and objective criteriaTimepoint: 3 weeks
- Secondary Outcome Measures
Name Time Method Fulfillment of subjective and objective criteriaTimepoint: 3 weeks